companies / kariusdx-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
Karius was listed in Khosla Ventures's portfolio, recorded 2026-09-27.
verified=2026-05-25 json
| total_raised | 100,000,000100.0M | ○ |
|---|---|---|
| founded | 2014 | |
| hq | Redwood City, USA | |
| industry | unknown | |
| stage | series-b+ |
Liquid-biopsy genomic diagnostics platform detecting pathogens from cell-free DNA for infectious disease
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2024-05-02 | series-c | 100,000,000100.0M | null | ○ |
| investor | src |
|---|---|
| Khosla Ventures | ○ |
unknown
| fact | status | src |
|---|---|---|
| Series C, $100.0M | attributed | ○ |
| Investor Khosla Ventures | sourced | WEB |
| existence | self-reported | WEB |
| description | self-reported | WEB |
| date | fact | change | src |
|---|---|---|---|
| 2026-09-27latest_round: series-c, $100.0M, 2024-05-02, lead: khosla → series-c, $100.0M, 2024-05-02, lead: null, ○ 2026-05-25 | latest_round | series-c, $100.0M, 2024-05-02, lead: khosla → series-c, $100.0M, 2024-05-02, lead: null | ○ 2026-05-25 |
| 2026-09-27provenance_investor_khosla: unknown → sourced, WEB 2026-09-27 | provenance_investor_khosla | unknown → sourced | WEB 2026-09-27 |
Records begin 2026-09-24. all_changes